D’Amico prostate-cancer risk classification
D'Amico risk classification (D'Amico 1998): low / intermediate / high risk of biochemical recurrence from PSA, Gleason score, and clinical T stage; the worst feature governs.
Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Serum PSA
- 6 ng/mL
- Gleason score
- 7
- Clinical T stage
- T1c
Result: Intermediate risk of biochemical recurrence (driven by Gleason; the worst feature governs).
The tool opens with these values already filled in. Replace them with your own.
What the result means
- Low
- clinical stage T2a or below AND PSA 10 or below AND Gleason 6 or below.
- Intermediate
- stage T2b OR PSA above 10 and up to 20 OR Gleason 7.
- High
- stage T2c OR PSA above 20 OR Gleason 8 or above; the worst single feature governs.
What you enter
- Serum PSA
- Gleason score (2-10)
- Clinical T stage
How this is calculated
D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969-974. Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.